Freezing Your Young Immune Cells for Future Health

A new service lets anyone with about five thousand dollars collect and freeze immune cells from a quick blood draw. The procedure lasts about fifteen minutes and can be done at a partner clinic or by a phlebotomist visiting the home in certain regions. About sixty milliliters of blood are taken, which is more than a typical draw. The sample is then processed to isolate peripheral blood mononuclear cells, a group that includes T cells, B cells, monocytes, and dendritic cells.

After isolation, the cells are frozen to minus one hundred fifty degrees Celsius and stored for a yearly fee of two hundred seventy dollars. The client retains ownership and may request the cells be released later, working with a doctor. The provider makes clear that this is not a treatment and does not promise any future medical benefit. Interest comes from people who follow the latest medical research and want a biological backup of their youth.

Medical experts say the stored cells remain biologically younger than the client’s current cells, which tend to decline with age. Patients who plan for long‑term health often ask about emerging cell‑based therapies for conditions like cancer and autoimmune disease. Cryopreservation technology already supports long‑term storage; a healthy baby was born from a thirty‑year‑old frozen embryo, showing the technique’s reliability.

The initial fee of four thousand nine hundred ninety‑five dollars covers harvesting, isolation, and one year of storage. After that, clients can continue paying to keep the cells frozen indefinitely. The goal is to give people a living sample they could potentially use in future medicine, though no guarantees exist today.